🧐💼 Di Supreme Court Put Hand For Sackler Family Opioid Mata, Wait Small For Check Am Well
⬇️ Pidgin ⬇️ ⬇️ Black American Slang ⬇️ English
Di way Supreme Court dey look am now, dem wan reason di palava where Purdue Pharma dey inside well-well, dey hold ground on top deal wey wan cover di Sackler family from case where people wan drag dem enter court sake of opioid wahala. Di deal sef fit see dem drop correct $6 billion to all di people wey dey shout for help. 💰🤝
Na so di court follow side with di Justice Department wey don already tell dem make dem no rush, hold dat plan well make dem see wassup. Justice Department dey yan say di Sackler family wey get Purdue Pharma, where dem dey produce OxyContin medicine, no suppose hide their head under law wey dey save people wey owe pass dem fit pay. 🚫💊
No be say court drop reason for di decision, dem just do am. Wetin we dey sure of na say dem wan hear tori about di case when December reach. ❄️⏳
Dis Supreme Court waka on top di bankruptcy agreement na another gbege inside di long tussle about how dem go take care of people wey suffer from di kain medicine wahala.
For May, U.S. Court of Appeals for Second Circuit follow back di plan after dem check am well as part of Purdue Pharma bankruptcy wayo. Na for 2019 di company talk say dem no fit again. For dat time sef, both di company and di Sackler family get plenty court case for head sake of opioid wahala. ⚖️
E normal say company wey dey shout bankruptcy fit dey safe from court mata, but di wayo part be say, dem wan carry dat same safety give di family wey get di company. Sackler family sef talk say dem no go gree any plan unless e protect dem from court wahala. 🛡️
Di U.S. Trustee Program, where be office under Justice Department, don dey shout since say dem no dey sure say bankruptcy judges fit stop lawsuit against company owners if dem never shout say dem no fit for their personal self.
Government sef talk say na different tori dem dey hear for federal appeals courts. Say dis kain agreement fit show bad example.
Di solicitor general, Elizabeth B. Prelogar, yan say di way appeals court take reason am, e fit cause big palava for bankruptcy law. She even call di agreement “kind release wey big pass big”. Say e fit touch plenty people wey no even gree for di plan, and e fit shake constitution. 📜✍️
Purdue Pharma sef release talk after di Thursday waka. Dem talk say dem believe say di bankruptcy plan correct.
Members of di Sackler family no dey control di medicine company again. But when everything don clear for bankruptcy, dem no go get hand for di company again. Dem go change di company name sef to Knoa Pharma and di people wey dem owe go dey control am. But di family money still dey fat. Some people talk say dem get reach $11 billion, and plenty dey hide for abroad. 💸🌍
People wey suffer from di medicine wahala don dey vex on top government side. Dem dey fear say e go delay their money again.
Whether you believe say Sackler family get hand for how opioid wahala take start or not, na big money dey at stake here. Victim groups talk say di Sackler family suppose drop di money now, e don tey wey people don dey wait. 💔🕰️
NOW IN BLACK AMERICAN SLANG
🧐💼 Supreme Court Puttin’ Brakes on Sackler Family’s Opioid Deal, Gonna Scope It Out
Alright, so here’s the deal. The Supreme Court ain’t about to let this slide without peepin’ game. They’re holdin’ back on a potential agreement with the Sackler fam that would keep ’em safe from all them opioid-related lawsuits. Now, this deal might have ’em droppin’ a cool $6 billion to make things right for those who got played. 💰🤝
With this move, the court’s backin’ the Justice Department, sayin’ “Hold up! Let’s take a minute to break this down”. The Justice Department ain’t feelin’ the fact that the Sackler folks, the big dogs behind Purdue Pharma (the ones pushin’ OxyContin), are tryna slide outta this situation by pullin’ some legal moves that ain’t meant for folks like them. 🚫💊
Nobody’s really breakin’ down the exact reasons behind the court’s choice, but word is they’re gonna dive deep into this mess come December. ❄️⏳
All this back-and-forth about the bankruptcy agreement? It’s just another layer to this ongoing drama ’bout how to do right by those hurt by the prescription drug scene.
Flashback to May, the U.S. Court of Appeals for the Second Circuit gave the green light to the plan. This was all part of Purdue Pharma tryna get their finances right after they hit rock bottom in 2019. During that hot minute, both the company and the Sackler crew had the legal heat on ’em ’cause of the opioid mess. ⚖️
Now, it ain’t new news for companies hittin’ hard times to catch a break from the law. But what’s got everyone talkin’ is how this plan might cover the Sackler folks too. They’ve been mad clear: no deal unless they get that lawsuit shield. 🛡️
The U.S. Trustee Program, which rolls with the Justice Department, is throwin’ some shade. They’re wonderin’ if those in charge can really shut down these lawsuits against big shots, especially if they ain’t even personally feelin’ that financial hurt.
Government peeps be split on this. They’re thinkin’ this agreement could be settin’ some kind of iffy standard.
Elizabeth B. Prelogar, the top dog lawyer, ain’t pullin’ punches. She’s sayin’ that rollin’ with this could flip the whole game and not in a good way. She’s callin’ out this deal for bein’ too broad, potentially messin’ with folks who ain’t even in on it, and that ain’t right. 📜✍️
After all the talk on Thursday, Purdue Pharma stepped up, sayin’ they believe they’re on the up-and-up with their plan.
Even though the Sackler crew ain’t runnin’ things at the company no more, once everything’s settled, they won’t even own it. The company’s gonna switch it up, callin’ themselves Knoa Pharma and let the ones they owe run it. But don’t get it twisted, the Sackler family still got mad stacks. Rumor has it they’re sittin’ on about $11 billion, and a lot of that’s tucked away overseas. 💸🌍
People hurt by this whole opioid situation? They’re mad tired of waitin’. They’re sayin’ all this back-and-forth ain’t helpin’ and they need that money ASAP. The Sackler family’s cash? It’s needed more than ever. 💔🕰️
NOW IN ENGLISH
🧐💼 Supreme Court Holds Off on Sackler Family’s Opioid Deal, Taking Time for a Closer Look
The Supreme Court seems intent on revisiting the issue surrounding Purdue Pharma, as they’ve put a hold on a potential agreement that would protect the Sackler family from opioid-related lawsuits. This agreement might mean that they’d be parting with a hefty $6 billion in favor of the affected parties. 💰🤝
By doing so, the court is in agreement with the Justice Department’s stance of slowing things down and scrutinizing the details. The department maintains that the Sackler family, owners of Purdue Pharma, which manufactures the medicine OxyContin, shouldn’t benefit from legal protections designed for those genuinely struggling with debt. 🚫💊
There weren’t any explicit reasons given for the court’s decision, but it’s been made clear they’re planning on diving into this case by December. ❄️⏳
This move by the Supreme Court in relation to the bankruptcy agreement adds yet another layer to the ongoing dispute about how to address those harmed by the prescription drug issue.
Back in May, the U.S. Court of Appeals for the Second Circuit endorsed the plan, examining it as part of Purdue Pharma’s bankruptcy restructuring. This was after the company declared bankruptcy in 2019. During that period, both the company and the Sackler family were under the legal spotlight due to the opioid crisis. ⚖️
While it’s common for bankrupt companies to get a respite from legal actions, what’s controversial here is the idea of extending this protection to the company’s owners. The Sackler family has made it clear they’d only consent to a deal if it included safeguarding them from legal repercussions. 🛡️
The U.S. Trustee Program, a branch of the Justice Department, has been vocal about their concerns. They’re unsure if bankruptcy judges can indefinitely halt lawsuits against company owners, especially if they haven’t personally declared bankruptcy.
Government sources indicate there’s a divide on this issue among federal appeals courts, suggesting this agreement could set an undesirable precedent.
Elizabeth B. Prelogar, the solicitor general, pointed out that siding with the appeals court might trigger significant complications for bankruptcy laws. She described the agreement as having an “unusually wide scope”, potentially affecting a large number of people who haven’t directly agreed to its terms, potentially causing constitutional ripples. 📜✍️
In response to the Thursday’s announcement, a spokesperson for Purdue Pharma stated their belief in the legitimacy of the bankruptcy plan.
Although the Sackler family has since relinquished control over the pharmaceutical company, they’ll cease to be owners once the bankruptcy process is concluded. The company is set to undergo a rebranding, taking on the name Knoa Pharma and being controlled by its debtors. Regardless, the family remains affluent, with estimates suggesting they possess around $11 billion, a considerable portion of which is in offshore accounts. 💸🌍
Those affected by the opioid predicament have voiced their frustrations regarding the government’s stance, fearing it could mean more delays in the compensation they’ve been waiting for.
No matter where one stands on the Sackler family’s involvement in the genesis and exacerbation of the opioid crisis, the reality is that a substantial amount of money is on the line. Groups representing the victims argue that the funds, which the Sackler family is providing in return for legal protection, are sorely needed right now. 💔🕰️
